National Institutes of Heatlh (NIH) intramural research program funding ZIA-DA000635 (Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section
GLP-1 RA-MWL leads to AT depletion, with associated skin laxity, volume loss, and accelerated aging, particularly in periorbital and midfacial regions
By potentially dampening inflammatory processes, GLP-1 receptor agonists may help stabilise atherosclerotic plaques, improve endothelial function, and reduce thrombotic risk
These are distinct, customized preparations and are not generic versions of Ozempic, Wegovy, or Mounjaro
Dose selection should weigh both curves
Inconsistent timing can cause those levels to fluctuate, which may chip away at how well the medication works over time